• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过形成N-烷基磺酸盐衍生物减轻地贝卡星诱导的大鼠肾毒性。

Reduction of dibekacin-induced nephrotoxicity in the rat by the formation of N-alkylsulfonate derivatives.

作者信息

Kitasato I, Niizato T, Watanabe T, Inouye S

机构信息

Research & Development, Meiji Seika Kaisha Ltd., Tokyo, Japan.

出版信息

Drugs Exp Clin Res. 1989;15(6-7):239-47.

PMID:2591296
Abstract

Seven N-alkylsulfonate derivatives of an aminoglycoside antibiotic, dibekacin, were prepared and their nephrotoxicity was examined. Using water-supplied and water-depleted rats and the BUN value as a nephrotoxic measure, dibekacin-di-N-methanesulfonate, pentasodium dibekacin-penta-N-methanesulfonate, -penta-N-ethanesulfonate, disodium dibekacin-di-N-methanesulfonate sesquisulfate, disodium and dipotassium dibekacin-di-N-ethanesulfonate sesquisulfates and sodium dibekacin-mono-N-ethane-sulfonate disulfate showed low nephrotoxicity as compared to that of the original dibekacin sulfate. Notably, dibekacin-di-N-methanesulfonate caused little change in the BUN value and was bioactive in vitro but not active in vivo against a Pseudomonas aeruginosa infection model in mice. Among the bioactive N-alkylsulfonates in vivo, disodium and dipotassium dibekacin-di-N-ethanesulfonate sesquisulfates showed a lower degree of elevation of BUN, urine volume and urine protein, lower mortality and better body weight gain than those of dibekacin sulfate during consecutive treatment for 12 and 28 days.

摘要

制备了氨基糖苷类抗生素地贝卡星的七种N - 烷基磺酸盐衍生物,并检测了它们的肾毒性。以给水和缺水大鼠以及血尿素氮(BUN)值作为肾毒性指标,与原始硫酸地贝卡星相比,地贝卡星二 - N - 甲磺酸盐、地贝卡星五钠 - 五 - N - 甲磺酸盐、 - 五 - N - 乙磺酸盐、地贝卡星二 - N - 甲磺酸盐倍半硫酸盐二钠、地贝卡星二 - N - 乙磺酸盐倍半硫酸盐二钠和二钾以及地贝卡星 - 单 - N - 乙磺酸盐二硫酸盐显示出较低的肾毒性。值得注意的是,地贝卡星二 - N - 甲磺酸盐使BUN值变化很小,在体外具有生物活性,但在体内对小鼠铜绿假单胞菌感染模型无活性。在体内具有生物活性的N - 烷基磺酸盐中,地贝卡星二 - N - 乙磺酸盐倍半硫酸盐二钠和二钾在连续治疗12天和28天期间,与硫酸地贝卡星相比,血尿素氮、尿量和尿蛋白的升高程度较低,死亡率较低,体重增加较好。

相似文献

1
Reduction of dibekacin-induced nephrotoxicity in the rat by the formation of N-alkylsulfonate derivatives.通过形成N-烷基磺酸盐衍生物减轻地贝卡星诱导的大鼠肾毒性。
Drugs Exp Clin Res. 1989;15(6-7):239-47.
2
Effect of glucarolactam on low-dose nephrotoxicities of dibekacin and gentamicin in Fischer rats.葡醛内酯对费希尔大鼠中地贝卡星和庆大霉素低剂量肾毒性的影响。
Drugs Exp Clin Res. 1989;15(6-7):249-59.
3
Comparative nephrotoxicity of dibekacin and gentamicin in rats.地贝卡星与庆大霉素对大鼠的肾毒性比较
Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):419-32.
4
[Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin].[地贝卡星的肾毒性、药代动力学及治疗效果的动物实验]
Arzneimittelforschung. 1981;31(3):473-7.
5
Renal histological and biochemical changes induced in the rat by dibekacin.
J Pharmacol Exp Ther. 1983 Jul;226(1):226-31.
6
Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin.
J Pharmacobiodyn. 1982 Sep;5(9):659-69. doi: 10.1248/bpb1978.5.659.
7
Effect of glucarolactam on ototoxicity of aminoglycoside antibiotics in guinea-pigs.葡甲胺对豚鼠氨基糖苷类抗生素耳毒性的影响。
Drugs Exp Clin Res. 1989;15(6-7):261-72.
8
Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.新型具有N-甲脒基的假二糖氨基糖苷类药物达替米星与阿司米星、阿米卡星及其他氨基糖苷类抗生素在动物体内肾毒性的比较。
Drugs Exp Clin Res. 1989;15(5):189-209.
9
Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.顺铂肾毒性由γ-谷氨酰转肽酶介导,而非通过C-S裂解酶调控的生物转化途径。
Toxicology. 2008 Jul 30;249(2-3):184-93. doi: 10.1016/j.tox.2008.05.006. Epub 2008 May 21.
10
Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats.磷霉素对脱水大鼠中地贝卡星诱导的肾毒性的保护作用方式。
J Pharmacobiodyn. 1982 Dec;5(12):941-50. doi: 10.1248/bpb1978.5.941.